167 related articles for article (PubMed ID: 22967611)
1. Monitoring the subcellular localization of doxorubicin in CHO-K1 using MEKC-LIF: liposomal carrier for enhanced drug delivery.
Ho JA; Fan NC; Jou AF; Wu LC; Sun TP
Talanta; 2012 Sep; 99():683-8. PubMed ID: 22967611
[TBL] [Abstract][Full Text] [Related]
2. Measurement of intracellular accumulation of anthracyclines in cancerous cells by direct injection of cell lysate in MEKC/LIF detection.
Mbuna J; Kaneta T; Imasaka T
Electrophoresis; 2010 Apr; 31(8):1396-404. PubMed ID: 20217860
[TBL] [Abstract][Full Text] [Related]
3. Distribution of zeptomole-abundant doxorubicin metabolites in subcellular fractions by capillary electrophoresis with laser-induced fluorescence detection.
Anderson AB; Ciriacks CM; Fuller KM; Arriaga EA
Anal Chem; 2003 Jan; 75(1):8-15. PubMed ID: 12530812
[TBL] [Abstract][Full Text] [Related]
4. Measuring the doxorubicin content of single nuclei by micellar electrokinetic capillary chromatography with laser-induced fluorescence detection.
Xiong G; Chen Y; Arriaga EA
Anal Chem; 2005 Jun; 77(11):3488-93. PubMed ID: 15924379
[TBL] [Abstract][Full Text] [Related]
5. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
[TBL] [Abstract][Full Text] [Related]
6. Micellar electrokinetic capillary chromatography reveals differences in intracellular metabolism between liposomal and free doxorubicin treatment of human leukemia cells.
Eder AR; Arriaga EA
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):115-22. PubMed ID: 16246643
[TBL] [Abstract][Full Text] [Related]
7. Monitoring incorporation, transformation and subcellular distribution of N-l-leucyl-doxorubicin in uterine sarcoma cells using capillary electrophoretic techniques.
Wang Y; Arriaga EA
Cancer Lett; 2008 Apr; 262(1):123-32. PubMed ID: 18194838
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
9. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
10. Separation of doxorubicin and doxorubicinol by cyclodextrin-modified micellar electrokinetic capillary chromatography.
Eder AR; Chen JS; Arriaga EA
Electrophoresis; 2006 Aug; 27(16):3263-70. PubMed ID: 16915573
[TBL] [Abstract][Full Text] [Related]
11. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ
Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
13. Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions.
Chen Y; Walsh RJ; Arriaga EA
Anal Chem; 2005 Apr; 77(8):2281-7. PubMed ID: 15828758
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
15. Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.
Shin DH; Choi KS; Park SA; Cho BS; Lee HS; Ryu JS; Kim TY; Lee CK; Song S; Chung YB
Arch Pharm Res; 2008 Oct; 31(10):1355-61. PubMed ID: 18958428
[TBL] [Abstract][Full Text] [Related]
16. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
Gabizon A; Catane R; Uziely B; Kaufman B; Safra T; Cohen R; Martin F; Huang A; Barenholz Y
Cancer Res; 1994 Feb; 54(4):987-92. PubMed ID: 8313389
[TBL] [Abstract][Full Text] [Related]
17. Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo.
Sun M; Wang Y; Shen J; Xiao Y; Su Z; Ping Q
Nanotechnology; 2010 Nov; 21(47):475101. PubMed ID: 21030757
[TBL] [Abstract][Full Text] [Related]
18. Modulation of doxorubicin resistance in multidrug-resistance cells by targeted liposomes combined with hyperthermia.
Gaber MH
J Biochem Mol Biol Biophys; 2002 Oct; 6(5):309-14. PubMed ID: 12385965
[TBL] [Abstract][Full Text] [Related]
19. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
[TBL] [Abstract][Full Text] [Related]
20. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
Upadhyay KK; Bhatt AN; Mishra AK; Dwarakanath BS; Jain S; Schatz C; Le Meins JF; Farooque A; Chandraiah G; Jain AK; Misra A; Lecommandoux S
Biomaterials; 2010 Apr; 31(10):2882-92. PubMed ID: 20053435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
